Sanofi to consolidate holding in Indian arm
This article was originally published in Scrip
Executive Summary
Hoechst GmbH, a 100% subsidiary of Sanofi-Aventis , plans to acquire a 10.27% stake in Aventis Pharma India from the United Breweries (UB) group for about Rs4.14 billion ($90.8 million).